Effect of Hormone Replacement Therapy on Cardiovascular Outcomes: A Meta-Analysis of Randomized Controlled Trials

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Yang, Dicheng ^a   Li, Jing ^b   Yuan, Zhongxiang ^a   Liu, Xu ^b  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b SHANGHAI CHEST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRADIOL VALERATE; PLACEBO;

ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COCHRANE LIBRARY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DISEASE ASSOCIATION; EMBASE; HEART DEATH; HEART INFARCTION; HEART PERFUSION; HORMONE SUBSTITUTION; HUMAN; MEDLINE; MENOPAUSAL SYNDROME; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SYSTEMATIC REVIEW;

CARDIOVASCULAR DISEASES; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; TREATMENT OUTCOME;

EID: 84877261667     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062329     Document Type: Article

References (34)

1. Stampfer M, Colditz G, (1991) Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20: 47-63.
2. Bush TL, Barrett-Connor E, Cowan LD, (1987) Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program follow-up study. Circulation 75: 1102-1109.
3. Grady D, Rueben SB, Pettiti DB, (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117: 1016-1037.
4. Hulley S, Grady D, Bush T, (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280: 605-13.
5. Herrington DM, Reboussin DM, Brosnihan KB, (2000) Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 343: 522-9.
6. DJ Magliano, SL Rogers, MJ Abramson, AM Tonkin, (2006) Hormone therapy and cardiovascular disease:a systematic review and meta-analysis. BJOG 113: 5-14.
7. Moher D, Liberati A, Tetzlaff J, Altman DG, Grp P (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Plos Medicine 6.
8. Jadad AR, Moore RA, Carroll D, (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17: 1-12.
9. Deeks JJ, Higgins JPT, Altman DG (2008) Analyzing data and undertaking meta-analyses. In: Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions 5.0.1. Oxford, UK: The Cochrane Collaboration: chap 9.
10. Higgins JPT, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-60.
11. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-88.
12. Ades AE, Lu G, Higgins JP, (2005) The interpretation of random-effects metaanalysis in decision models. Med Decis Making 25: 646-54.
13. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-34.
14. The HERS Research Group (2001) Postmenopausal Hormone Therapy and Risk of Stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Circulation 103: 638-642.
15. The HERS Research Group (2002) Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II). JAMA 288: 49-57.
16. The WAVE Study Group (2002) Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA 288: 2432-2440.
17. The Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial. JAMA 288: 321-333.
18. The Women's Health Initiative Investigators (2003) Estrogen plus Progestin and the Risk of Coronary Heart Disease. N Engl J Med 349: 523-34.
19. The Women's Health Initiative Investigators (2003) Effect of estrogen plus progestin on stroke in postmenopausal women: the women's health initiative: a randomized trial. JAMA 289: 2673-2684.
20. The WEST Study Group (2001) A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 345: 1243-9.
21. The ESPRIT Team (2002) Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. Lancet 360: 2001-08.
22. The Women's Health Initiative Steering Committee (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 291: 1701-1712.
23. The EPAT Study Group (2001) Estrogen in the Prevention of Atherosclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial. Ann Intern Med 135: 939-953.
24. P Veerus, Hovi SL, Fischer K, Rahu M, Hakama M, et al. (2006) Results from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757]. Maturitas 55: 162-173.
25. The WISDOM Team (2007) Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women. BMJ 335 (7613): 239.
26. Grodstein F, Stampfer M, (1995) The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 38: 199-210.
27. Manson JE, Martin KA, (2001) Postmenopausal hormone-replacement therapy. N Engl J Med 345: 34-40.
28. Shlipak MG, Simon JA, Vittinghoff E, (2000) Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. JAMA 283: 1845-52.
29. Cushman M, Legault C, Barrett-Connor E, (1999) Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation 100: 717-22.
30. Mendelsohn ME, Karas RH, (1999) The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801-11.
31. Prospective Studies Collaboration, (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360: 1903-1913.
32. Vasan RS, Larson MG, Leip EP, (2001) Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 345: 1291-1297.
33. Emerging Risk Factors Collaboration, (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375: 132-40.
34. Marjoribanks J, Farquhar C, Roberts H, Lethaby A (2012) Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews: CD004143.